Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

CHMP recommends EU approval of FREHEMGO as the first factor VIIIa mimetic to offer monthly, biweekly, and weekly dosing through a pre-filled pen for haemophilia A treatment


Novartis’s Cosentyx® receives positive CHMP opinion for treating polymyalgia rheumatica


Novo Nordisk and Anthropic to team up on accelerating drug discovery through Claude


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Case Study: CMC Biologics Explores the Potential of Continuous Multi-Column Chromatography

Presented by Michelle Najera, PhD, CMC Biologics, Downstream Process Development Scientist and Lynne Frick, Director of Sales, Continuous Bioprocessing, Pall Life Sciences
06th February 2017


Handling mutagenic extractable and leachable compounds released from devices

Presented by Ron Brown, Toxicologist at Risk Science Consortium and Piet Christieans, PhD, Scientific Director at Nelson Labs
10th February 2022


Case Study and Experience on Sanofi’s and SGS’s Implementation of BPOG’s Leachable Risk Assessment Model

Presented by Ken Wong, Deputy Director at Sanofi Pasteur and Dujuan Lu, Manager/Global Lead of E&L at SGS
10th September 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia